— Know what they know.
Not Investment Advice
Also trades as: 0KHE.L (LSE) · $vol 0M

RVTY NYSE

Revvity, Inc.
1W: -1.0% 1M: +1.2% 3M: -4.9% YTD: -2.7% 1Y: +2.1% 3Y: -15.9% 5Y: -32.8%
$96.95
+1.57 (+1.65%)
 
Weekly Expected Move ±7.9%
$79 $87 $94 $101 $109
NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 62 · $10.8B mcap · 102M float · 1.16% daily turnover · Short 73% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$2.9B +3.7% ▲
5Y CAGR: -5.5%
Gross Profit
$1.5B +14.6% ▲
5Y CAGR: -5.3%
Operating Income
$357M -13.1% ▼
5Y CAGR: -19.0%
Net Income
$242M -18.3% ▼
5Y CAGR: -19.8%
EPS (Diluted)
$2.08 -13.7% ▼
5Y CAGR: -20.4%
EBITDA
$663M -21.1% ▼
5Y CAGR: -11.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$3.8B$3.3B$2.8B$2.8B$2.9B
YoY Growth+1.2%-13.5%-16.9%+0.2%+3.7%
Cost of Revenue$1.5B$1.6B$1.4B$1.4B$1.3B
Gross Profit$2.3B$1.8B$1.3B$1.3B$1.5B
Gross Margin59.6%53.2%48.1%48.0%53.1%
R&D Expenses$200M$222M$217M$197M$216M
SG&A Expenses$742M$758M$706M$715M$945M
Operating Expenses$942M$980M$923M$912M$1.2B
Operating Income$1.3B$781M$399M$411M$357M
Operating Margin35.0%23.6%14.5%14.9%12.5%
Interest Expense$102M$104M$99M$96M$92M
Income Before Tax$1.2B$652M$183M$316M$268M
Tax Expense$314M$139M$3M$33M$26M
Net Income$943M$569M-$118M$296M$242M
Net Margin24.6%17.2%-4.3%10.7%8.5%
EPS (Diluted)$8.08$4.50$-0.95$2.41$2.08
EBITDA$1.6B$1.2B$714M$840M$663M
Shares Outstanding117M126M125M123M113M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms